Unigene Laboratories Information
Ashleigh Palmer, President and CEO Gregory T. Mayes, Esq., Vice President, Corporate Development and General Counsel Nozer Mehta, Ph.D., Vice President, Biological Research and Development Paul Shields, Ph.D., Vice President, Technology Transfer and Contract Manufacturing Services William Steinhauer, CPA Vice President, Finance Roxanne Tavakkol, Vice President, Global Regulatory Affairs Jenene Thomas,
Vice President, Investor Relations and Business AdministrationUnigene Laboratories (OTC:UGNE) is a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey.
The company's primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis. The company has licensed worldwide rights to its oral parathyroid hormone ("PTH") to GlaxoSmithKline.
External links
Categories:
|